Krystal Biotech to Present at 5th Annual Evercore ISI HealthCONx Conference
November 23 2022 - 7:00AM
Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) a
biotechnology company focused on developing and commercializing
genetic medicines for patients with rare diseases, announced today
that the Company will participate in the Evercore ISI 5th Annual
HealthCONx Conference, which is taking place virtually from
November 29-December 1.
Krish S. Krishnan, Chairman and Chief Executive Officer, will
participate in a fireside chat during the conference and host
investor meetings on November 30.
A webcast of the presentation will be available here at 10:30 am
ET on Wednesday, November 30 and will be posted on the Investor
section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a biotechnology company
focused on developing and commercializing genetic medicines for
patients with rare diseases. The Company’s wide-ranging pipeline is
based on its proprietary redosable HSV vector. Headquartered in
Pittsburgh, Pennsylvania, the Company is led by an experienced
management team, is fully-integrated and has core capabilities in
viral vector design, vector optimization, gene therapy
manufacturing and commercialization. For more information, please
visit http://www.krystalbio.com, and follow @KrystalBiotech on
LinkedIn and Twitter.
CONTACT:
Investors and Media
Meg Dodge
Krystal Biotech
mdodge@krystalbio.com
Source: Krystal Biotech, Inc.
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Oct 2023 to Oct 2024